Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 293

1.

Random effects models for estimation of the probability and time to progression of a continuous biomarker.

Reddy T, Molenberghs G, Bruckers L, Njagi EN, Aerts M, Willem Schurink G.

Pharm Stat. 2019 Jul 15. doi: 10.1002/pst.1956. [Epub ahead of print]

PMID:
31309691
2.

University of Pennsylvania 11th annual conference on statistical issues in clinical trials: Estimands, missing data and sensitivity analysis (morning panel session).

Rockhold FW, Lindblad A, Siegel JP, Molenberghs G.

Clin Trials. 2019 Jul 13:1740774519853573. doi: 10.1177/1740774519853573. [Epub ahead of print] No abstract available.

PMID:
31303021
3.

Determinants of unit nonresponse in multi-mode data collection: A multilevel analysis.

Berete F, Van der Heyden J, Demarest S, Charafeddine R, Gisle L, Braekman E, Tafforeau J, Molenberghs G.

PLoS One. 2019 Apr 26;14(4):e0215652. doi: 10.1371/journal.pone.0215652. eCollection 2019.

4.

Defining Efficacy Estimands in Clinical Trials: Examples Illustrating ICH E9(R1) Guidelines.

Ratitch B, Goel N, Mallinckrodt C, Bell J, Bartlett JW, Molenberghs G, Singh P, Lipkovich I, O'Kelly M.

Ther Innov Regul Sci. 2019 Apr 9:2168479019841316. doi: 10.1177/2168479019841316. [Epub ahead of print]

PMID:
30966778
5.

Aligning Estimators With Estimands in Clinical Trials: Putting the ICH E9(R1) Guidelines Into Practice.

Mallinckrodt CH, Bell J, Liu G, Ratitch B, O'Kelly M, Lipkovich I, Singh P, Xu L, Molenberghs G.

Ther Innov Regul Sci. 2019 Apr 7:2168479019836979. doi: 10.1177/2168479019836979. [Epub ahead of print]

PMID:
30955353
6.

Choosing Estimands in Clinical Trials: Putting the ICH E9(R1) Into Practice.

Ratitch B, Bell J, Mallinckrodt C, Bartlett JW, Goel N, Molenberghs G, O'Kelly M, Singh P, Lipkovich I.

Ther Innov Regul Sci. 2019 Apr 4:2168479019838827. doi: 10.1177/2168479019838827. [Epub ahead of print]

PMID:
30947539
7.

A reflection on the causal interpretation of individual-level surrogacy.

Alonso A, Van Der Elst W, Molenberghs G, Florez AJ.

J Biopharm Stat. 2019;29(3):529-540. doi: 10.1080/10543406.2019.1579221. Epub 2019 Feb 16.

PMID:
30773114
8.

A reflection on the possibility of finding a good surrogate.

Alonso A, Meyvisch P, Van der Elst W, Molenberghs G, Verbeke G.

J Biopharm Stat. 2019;29(3):468-477. doi: 10.1080/10543406.2018.1559854. Epub 2019 Jan 26.

PMID:
30686082
9.

Maternal and peer attachment, identity formation, and non-suicidal self-injury: a longitudinal mediation study.

Gandhi A, Luyckx K, Molenberghs G, Baetens I, Goossens L, Maitra S, Claes L.

Child Adolesc Psychiatry Ment Health. 2019 Jan 19;13:7. doi: 10.1186/s13034-019-0267-2. eCollection 2019.

10.

The changing landscape of data monitoring committees-Perspectives from regulators, members, and sponsors.

Bhattacharyya A, Gallo P, Crisp A, LaVange L, Molenberghs G, Pétavy F, Seltzer J.

Biom J. 2018 Dec 27. doi: 10.1002/bimj.201700307. [Epub ahead of print] Review.

PMID:
30589102
11.

Assessing the predictive value of a binary surrogate for a binary true endpoint based on the minimum probability of a prediction error.

Meyvisch P, Alonso A, Van der Elst W, Molenberghs G.

Pharm Stat. 2019 May;18(3):304-315. doi: 10.1002/pst.1924. Epub 2018 Dec 21.

PMID:
30575256
12.

A closed-form estimator for meta-analysis and surrogate markers evaluation.

Flórez AJ, Molenberghs G, Verbeke G, Abad AA.

J Biopharm Stat. 2019;29(2):318-332. doi: 10.1080/10543406.2018.1535504. Epub 2018 Oct 26.

PMID:
30365364
13.

Improved discrimination between normal-tension and primary open-angle glaucoma with advanced vascular examinations - the Leuven Eye Study.

Barbosa-Breda J, Van Keer K, Abegão-Pinto L, Nassiri V, Molenberghs G, Willekens K, Vandewalle E, Rocha-Sousa A, Stalmans I.

Acta Ophthalmol. 2019 Feb;97(1):e50-e56. doi: 10.1111/aos.13809. Epub 2018 Sep 17.

PMID:
30225863
14.

A maximum entropy approach for the evaluation of surrogate endpoints based on causal inference.

Alonso A, Van der Elst W, Molenberghs G.

Stat Med. 2018 Dec 20;37(29):4525-4538. doi: 10.1002/sim.7939. Epub 2018 Aug 23.

PMID:
30141219
15.

Analyses of the short- and long-term graft survival after kidney transplantation in Europe between 1986 and 2015.

Coemans M, Süsal C, Döhler B, Anglicheau D, Giral M, Bestard O, Legendre C, Emonds MP, Kuypers D, Molenberghs G, Verbeke G, Naesens M.

Kidney Int. 2018 Nov;94(5):964-973. doi: 10.1016/j.kint.2018.05.018. Epub 2018 Jul 24.

PMID:
30049474
16.

Evaluation of six months sputum culture conversion as a surrogate endpoint in a multidrug resistant-tuberculosis trial.

Meyvisch P, Kambili C, Andries K, Lounis N, Theeuwes M, Dannemann B, Vandebosch A, Van der Elst W, Molenberghs G, Alonso A.

PLoS One. 2018 Jul 19;13(7):e0200539. doi: 10.1371/journal.pone.0200539. eCollection 2018.

17.

Measurement agreement of the self-administered questionnaire of the Belgian Health Interview Survey: Paper-and-pencil versus web-based mode.

Braekman E, Berete F, Charafeddine R, Demarest S, Drieskens S, Gisle L, Molenberghs G, Tafforeau J, Van der Heyden J, Van Hal G.

PLoS One. 2018 May 21;13(5):e0197434. doi: 10.1371/journal.pone.0197434. eCollection 2018.

18.

Lessons learned from IDeAl - 33 recommendations from the IDeAl-net about design and analysis of small population clinical trials.

Hilgers RD, Bogdan M, Burman CF, Dette H, Karlsson M, König F, Male C, Mentré F, Molenberghs G, Senn S.

Orphanet J Rare Dis. 2018 May 11;13(1):77. doi: 10.1186/s13023-018-0820-8. Review.

19.

Response to comments on "Marginalized multilevel hurdle and zero-inflated models for overdispersed and correlated count data with excess zeros".

Molenberghs G, Poveda AF, Kassahun W, Neyens T, Faes C, Verbeke G.

Stat Med. 2018 May 20;37(11):1942-1946. doi: 10.1002/sim.7596. No abstract available.

PMID:
29732614
20.

An evaluation of the trimmed mean approach in clinical trials with dropout.

Wang MD, Liu J, Molenberghs G, Mallinckrodt C.

Pharm Stat. 2018 May;17(3):278-289. doi: 10.1002/pst.1858. Epub 2018 Apr 6.

PMID:
29624854
21.

On using multiple imputation for exploratory factor analysis of incomplete data.

Nassiri V, Lovik A, Molenberghs G, Verbeke G.

Behav Res Methods. 2018 Apr;50(2):501-517. doi: 10.3758/s13428-017-1013-4. Review.

PMID:
29392587
22.

On using multiple imputation for exploratory factor analysis of incomplete data.

Nassiri V, Lovik A, Molenberghs G, Verbeke G.

Behav Res Methods. 2018 Jan 31. doi: 10.3758/s13428-017-1000-9. [Epub ahead of print]

PMID:
29388116
23.

Cluster analysis for repeated data with dropout: Sensitivity analysis using a distal event.

Bruckers L, Molenberghs G, Pulinx B, Hellenthal F, Schurink G.

J Biopharm Stat. 2018;28(5):983-1004. doi: 10.1080/10543406.2018.1428612. Epub 2018 Jan 29.

PMID:
29376762
24.

Local influence diagnostics for hierarchical finite-mixture random-effects models.

Rakhmawati TW, Molenberghs G, Verbeke G, Faes C.

Biom J. 2018 Mar;60(2):369-380. doi: 10.1002/bimj.201600203. Epub 2017 Dec 19.

PMID:
29265409
25.

Joint modeling of multiple ordinal adherence outcomes via generalized estimating equations with flexible correlation structure.

Jiang Z, Liu Y, Wahed AS, Molenberghs G.

Stat Med. 2018 Mar 15;37(6):983-995. doi: 10.1002/sim.7560. Epub 2017 Dec 13.

PMID:
29235127
26.

Editorial "Joint modeling of longitudinal and time-to-event data and beyond".

Cadarso Suárez C, Klein N, Kneib T, Molenberghs G, Rizopoulos D.

Biom J. 2017 Nov;59(6):1101-1103. doi: 10.1002/bimj.201700180. No abstract available.

PMID:
29139604
27.

Thyroid Cancer Incidence around the Belgian Nuclear Sites, 2000-2014.

Demoury C, De Smedt T, De Schutter H, Sonck M, Van Damme N, Bollaerts K, Molenberghs G, Van Bladel L, Van Nieuwenhuyse A.

Int J Environ Res Public Health. 2017 Aug 31;14(9). pii: E988. doi: 10.3390/ijerph14090988.

28.

Dynamic predictions with time-dependent covariates in survival analysis using joint modeling and landmarking.

Rizopoulos D, Molenberghs G, Lesaffre EMEH.

Biom J. 2017 Nov;59(6):1261-1276. doi: 10.1002/bimj.201600238. Epub 2017 Aug 9.

PMID:
28792080
29.

Discussion: Is the FDA in need of a major change in the way it regulates?

Molenberghs G.

Biostatistics. 2017 Jul 1;18(3):408-410. doi: 10.1093/biostatistics/kxx020. No abstract available.

PMID:
28633316
30.

The Relation Between Aggression and the Living Group Climate in a Forensic Treatment Unit for Adolescents: A Pilot Study.

de Decker A, Lemmens L, van der Helm P, Bruckers L, Molenberghs G, Tremmery S.

Int J Offender Ther Comp Criminol. 2018 May;62(7):1821-1837. doi: 10.1177/0306624X17712347. Epub 2017 Jun 19.

PMID:
28627274
31.

Fast precision estimation in high-dimensional multivariate joint models.

Nassiri V, Ivanova A, Molenberghs G, Verbeke G.

Biom J. 2017 Nov;59(6):1221-1231. doi: 10.1002/bimj.201600241. Epub 2017 Jun 16.

PMID:
28620935
32.

Sample substitution can be an acceptable data-collection strategy: the case of the Belgian Health Interview Survey.

Demarest S, Molenberghs G, Van der Heyden J, Gisle L, Van Oyen H, de Waleffe S, Van Hal G.

Int J Public Health. 2017 Nov;62(8):949-957. doi: 10.1007/s00038-017-0976-3. Epub 2017 May 3.

PMID:
28470413
33.

Clustering multiply imputed multivariate high-dimensional longitudinal profiles.

Bruckers L, Molenberghs G, Dendale P.

Biom J. 2017 Sep;59(5):998-1015. doi: 10.1002/bimj.201500027. Epub 2017 Apr 24.

PMID:
28436052
34.

Parametric overdispersed frailty models for current status data.

Abrams S, Aerts M, Molenberghs G, Hens N.

Biometrics. 2017 Dec;73(4):1388-1400. doi: 10.1111/biom.12692. Epub 2017 Mar 27.

PMID:
28346819
35.

Multinomial additive hazard model to assess the disability burden using cross-sectional data.

Yokota RTC, Van Oyen H, Looman CWN, Nusselder WJ, Otava M, Kifle YW, Molenberghs G.

Biom J. 2017 Sep;59(5):901-917. doi: 10.1002/bimj.201600157. Epub 2017 Mar 23.

PMID:
28332222
36.

Remote Monitoring of Hypertension Diseases in Pregnancy: A Pilot Study.

Lanssens D, Vandenberk T, Smeets CJ, De Cannière H, Molenberghs G, Van Moerbeke A, van den Hoogen A, Robijns T, Vonck S, Staelens A, Storms V, Thijs IM, Grieten L, Gyselaers W.

JMIR Mhealth Uhealth. 2017 Mar 9;5(3):e25. doi: 10.2196/mhealth.6552.

37.

Establishing normative data for multi-trial memory tests: the multivariate regression-based approach.

Van der Elst W, Molenberghs G, van Tetering M, Jolles J.

Clin Neuropsychol. 2017 Aug - Oct;31(6-7):1173-1187. doi: 10.1080/13854046.2017.1294202. Epub 2017 Feb 17.

PMID:
28276864
38.

The ER Stress Sensor PERK Coordinates ER-Plasma Membrane Contact Site Formation through Interaction with Filamin-A and F-Actin Remodeling.

van Vliet AR, Giordano F, Gerlo S, Segura I, Van Eygen S, Molenberghs G, Rocha S, Houcine A, Derua R, Verfaillie T, Vangindertael J, De Keersmaecker H, Waelkens E, Tavernier J, Hofkens J, Annaert W, Carmeliet P, Samali A, Mizuno H, Agostinis P.

Mol Cell. 2017 Mar 2;65(5):885-899.e6. doi: 10.1016/j.molcel.2017.01.020. Epub 2017 Feb 23.

39.

Microbial Performance of Food Safety Control and Assurance Activities in a Fresh Produce Processing Sector Measured Using a Microbial Assessment Scheme and Statistical Modeling.

Njage PM, Sawe CT, Onyango CM, Habib I, Njagi EN, Aerts M, Molenberghs G.

J Food Prot. 2017 Jan;80(1):177-188. doi: 10.4315/0362-028X.JFP-16-233.

PMID:
28221882
40.

The analysis of multivariate longitudinal data: A review.

Verbeke G, Fieuws S, Molenberghs G, Davidian M.

Stat Methods Med Res. 2017 Feb;26(1):112. doi: 10.1177/0962280214539862. No abstract available.

PMID:
28054505
41.

Local influence diagnostics for hierarchical count data models with overdispersion and excess zeros.

Rakhmawati TW, Molenberghs G, Verbeke G, Faes C.

Biom J. 2016 Nov;58(6):1390-1408. doi: 10.1002/bimj.201500162. Epub 2016 Jun 29.

PMID:
27356111
42.

Estimating the reliability of repeatedly measured endpoints based on linear mixed-effects models. A tutorial.

Van der Elst W, Molenberghs G, Hilgers RD, Verbeke G, Heussen N.

Pharm Stat. 2016 Nov;15(6):486-493. doi: 10.1002/pst.1787. Epub 2016 Sep 29.

PMID:
27681820
43.

Implementation of pattern-mixture models in randomized clinical trials.

Bunouf P, Molenberghs G.

Pharm Stat. 2016 Nov;15(6):494-506. doi: 10.1002/pst.1780. Epub 2016 Sep 23.

PMID:
27658505
44.

A novel approach to estimation of the time to biomarker threshold: applications to HIV.

Reddy T, Molenberghs G, Njagi EN, Aerts M.

Pharm Stat. 2016 Nov;15(6):541-549. doi: 10.1002/pst.1774. Epub 2016 Sep 1.

PMID:
27580636
45.

Maternal body fluid composition in uncomplicated pregnancies and preeclampsia: a bioelectrical impedance analysis.

Staelens AS, Vonck S, Molenberghs G, Malbrain ML, Gyselaers W.

Eur J Obstet Gynecol Reprod Biol. 2016 Sep;204:69-73. doi: 10.1016/j.ejogrb.2016.07.502. Epub 2016 Aug 3.

PMID:
27525683
46.

Choosing estimands in clinical trials with missing data.

Mallinckrodt C, Molenberghs G, Rathmann S.

Pharm Stat. 2017 Jan;16(1):29-36. doi: 10.1002/pst.1765. Epub 2016 Aug 5.

PMID:
27492760
47.

Diagnosing misspecification of the random-effects distribution in mixed models.

Drikvandi R, Verbeke G, Molenberghs G.

Biometrics. 2017 Mar;73(1):63-71. doi: 10.1111/biom.12551. Epub 2016 Jul 5.

PMID:
27377556
48.

[Reaction on 'Risk factors and protective factors relating to suicide in the Netherlands and Flanders'].

Reynders A, Kerkhof AD, Molenberghs G, Van Audenhove C.

Tijdschr Psychiatr. 2016;58(4):343-4. Dutch. No abstract available.

PMID:
27187999
49.

Properties of Estimators in Exponential Family Settings with Observation-based Stopping Rules.

Milanzi E, Molenberghs G, Alonso A, Kenward MG, Verbeke G, Tsiatis AA, Davidian M.

J Biom Biostat. 2016 Feb;7(1). pii: 272. Epub 2016 Jan 25.

50.

Detecting influential observations in a model-based cluster analysis.

Bruckers L, Molenberghs G, Verbeke G, Geys H.

Stat Methods Med Res. 2018 Feb;27(2):521-540. doi: 10.1177/0962280216634112. Epub 2016 Mar 17.

PMID:
26994214

Supplemental Content

Loading ...
Support Center